Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol with or without methyl ergometrine for first-trimester medical abortion
IRCT20250818066905N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Rate of complete abortion. Started Sep 2025; status: completed.
02
Drugs
misoprostol
Beyond the preview
Go deeper on IRCT20250818066905N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250818066905N1.